Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Return on Equity %

Arbutus Biopharma Cp Return on Equity % Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Return on Equity % from 2010 to 2018.
  • Arbutus Biopharma Cp Return on Equity % for the quarter ending December 12, 2018 was -35.22 a 4.57% decrease of -1.61 year over year
  • Arbutus Biopharma Cp Return on Equity % for the last 12 months ending December 12, 2018 was -29.84 a -32.31% increase of 9.64 year over year
  • Arbutus Biopharma Cp Annual Return on Equity % for 2018 was -29.84 a -46.72% increase of 13.94 from 2017
  • Arbutus Biopharma Cp Annual Return on Equity % for 2017 was -43.79 a -133.75% increase of 58.56 from 2016
  • Arbutus Biopharma Cp Annual Return on Equity % for 2016 was -102.35 a 80.72% decrease of -82.62 from 2015
Other Margins & Efficiency Metrics:
  • Arbutus Biopharma Cp EBITDA Margin for the quarter ending September 09, 2017 was $-142m a -71.85% increase of 102m year over year
  • Arbutus Biopharma Cp Return on Capital % for the quarter ending December 12, 2018 was -19.07 a -3.10% increase of 0.59 year over year
View Chart On Koyfin

Quarterly ABUS Return on Equity % Data

12/2018-35.22
09/2018-43.19
06/20185.27
03/2018-33.61
12/2017-82.16
09/2017-27.04
06/2017-40.02
03/2017-38.00
12/2016-282.36
09/2016-18.49

Annual ABUS Return on Equity % Data

2018-29.84
2017-43.79
2016-102.35
2015-19.73
2014-52.76
2013-28.09
2012128.33
2011-127.75
2010-74.80
2009-25.34